Anticuerpos monoclonales en COVID 19: Casirivimab+Imdevimab.

dc.contributor.authorInstituto Global para la Excelencia en el Cuidado de la Salud Keralty
dc.date.accessioned2026-04-10T15:42:31Z
dc.date.available2026-04-10T15:42:31Z
dc.date.issued2021
dc.formattext
dc.identifier.urihttps://repositorio.unisanitas.edu.co/handle/123456789/1181
dc.language.isoes
dc.publisherKeralty
dc.titleAnticuerpos monoclonales en COVID 19: Casirivimab+Imdevimab.
dc.typeDocumento
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ETES Casirivimab COVID19 IH 2021.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.15 KB
Format:
Item-specific license agreed to upon submission
Description: